Clinical Trials Search at Vanderbilt-Ingram Cancer Center

NRG-CC015: Harnessing E-Mindfulness Approaches for Living-After Breast Cancer---HEAL-ABC

Breast

A Prospective Phase 3 Study of Patients with Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma.

Pediatrics

A Phase 3, Randomized, Double-blind, Add-on Study Evaluating the Safety and Efficacy of Navtemadlin Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Nave Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Hematologic

A Phase 2, Multicenter, Multi Arm, Study to Evaluate Pembrolizumab (MK- 3475) or MK-1308A (Co-formulated quavonlimab (MK-1308)/pembrolizumab) in Participants with Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer: (MK-1308A-008)

A Phase II Neoadjuvant Clinical Trial of the Androgen Receptor Inhibitor Darolutamide in Early-Stage Androgen Receptor Positive (AR+) Triple-Negative Breast Cancer

Breast

Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)

Neuroendocrine

A Single Arm Phase 2 Trial of Atezolizumab with Sacituzumab Govitecan to Prevent Recurrence in Triple Negative Breast Cancer (ASPRIA)

Breast

A Randomized Trial Of Neratinib, A PAN-ERBB Inhibitor, Alone or in Combination with Palbociclib, A CDK/6 Inhibitor, in Patients With HER2+ Gynecologic Cancers And Other Solid Tumors A ComboMATCH Treatment Trial

MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of Adjuvant Therapy in Urothelial Cancer

NMTT-Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

Multiple Cancer Types